5-Azacytidine modulates the response of sensitive and multidrug-resistant K562 leukemic cells to cytostatic drugs

Blood Cells, Molecules, and Diseases

Volumn 27, Issue 3, 2001, Pages 637-648

  Efferth, Thomas ^a,c   Futscher, Bernard W ^b   Osieka, Rainhardt ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF ARIZONA   (United States)

^c Virtual Campus Rhineland Palatinate ^*  (Germany)

Author keywords

Bisulfite sequencing; HpaII sensitive PCR; PCR stop assay

Indexed keywords

AZACITIDINE; CARRIER PROTEINS AND BINDING PROTEINS; CISPLATIN; CYTOSTATIC AGENT; DAUNORUBICIN; ETOPOSIDE; VINCRISTINE;

APOPTOSIS; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CELL KINETICS; COMPARATIVE STUDY; CONTROLLED STUDY; CPG ISLAND; DRUG SENSITIVITY; FLOW CYTOMETRY; GENE AMPLIFICATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; METHYLATION; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034886145     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2001.0427     Document Type: Article

References (43)

1. Treatment of acute myelogenous leukemia in older adults
2. Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL)
3. Resistance to cisplatin
4. Hemimethylated duplex DNAs prepared from 5-azacytidine-treated cells
5. Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2′-deoxycytidine
6. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines
7. Cytidine methylation of regulatory sequences near the p-class glutathione S-transferase gene accompanies human prostatic carcinogenesis
8. Suppression of intestinal neoplasia by DNA hypomethylation
9. The DNA methylation machinery as a target for anticancer therapy
10. Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells
11. Clustering of undermethylated CCGG and GCGC sequences in the 5′ region of the Ha-RAS-1 oncogene of human leukemic K562 cells
12. Comparative evaluation of several DNA binding dyes in the detection of apoptosis associated with chromatin degradation by flow cytometry
13. Anti-Fas/Apo-1 monoclonal antibody CH-11 depletes glutathione and kills multidrug-resistant human leukemic cells
14. Apoptosis and resistance to daunorubicin in human leukemic cells
15. mRNA phenotyping by enzymatic amplification of randomly primed cDNA
16. Damage of the kinesin heavy chain gene contributes to the antagonism of cisplatin and paclitaxel
17. 6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene
18. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells
19. A polymerase chain reaction-based method to detect cisplatin adducts in specific genes
20. Gene-specific damage produced by cisplatin, ormaplatin and UV light in human cells as assayed by the polymerase chain reaction
21. DNA damage and apoptosis in mononuclear cells from glucose -6-phosphate dehydrogenase deficient patients (G6PD Aachen variant) after UV-irradiation
22. Molecular study of eight Japanese cases of glucose-6-phosphate dehydrogenase deficiency by nonradioisotopic single-strand confirmation polymorphism analysis
23. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene
24. Silencing of the VHL tumor suppressor gene by DNA methylation in renal cell carcinoma
25. Tissue-specific transcriptional regulation of human leukosialin (CD43) gene is achieved by DNA methylation
26. 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers
27. Modulation of MDR1 gene expression and function in human K562 leukemic cells by 5-azacytidine
28. Decitabine (5-aza-2′-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells
29. Activation of MDR1 gene expression is associated with cytosine methylation of its CpG island
30. Demethylation of the human MDR1 5′region accompanies activation of P-glycoprotein expression in a HL60 multidrug resistant subline
31. Altered methylation of the human MDR1 promotor is associated with acquired multidrug resistance
32. Hypomethylation status of CpG sites at the promotor region and overexpression of the human MDR1 gene in acute myeloid leukemias
33. Methylation analysis of the human multidrug resistance 1 gene in normal and leukemic hematopoietic cells
34. The mechanism of trans-activation of the MDR1 gene by human T cell leukemia virus
35. Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA
36. Fragile sites induced by 5-azacytidine and 5-azadeoxycytidine in the murine genome
37. Novel ex vivo analysis of nonclassical, pleiotropic drug resistance and collateral sensitivity induced by therapy provides a rationale for treatment strategies in chronic lymphocytic leukemia
38. Drug-induced DNA hypermethylation and drug resistance in human tumors
39. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients
40. Induction failure in childhood acute nonlymphocytic leukemia: Etoposide/5-azacytidine for cases refractory to daunorubicin/cytarabine
41. Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia
42. Chronic myelogenous leukemia in nonlymphoid blastic phase: Analysis of the results of first salvage therapy with three different treatment approaches for 162 patients
43. A phase I trial of cisplatin plus decitabine, a new DNA-hypomethylating agent, in patients with advanced solid tumors and a follow-up early phase II evaluation in patients with inoperable non-small cell lung cancer